What is the best clinical approach to adolescents with obesity and metabolic syndrome? [0.03%]
青少年肥胖和代谢综合征的最佳临床治疗方法是什么？
Ana Raimunda Dâmaso,Lian Tock,Nayra Figueiredo et al.
Ana Raimunda Dâmaso et al.
Outcomes of single anastomosis duodeno ileal bypass and single anastomosis stomach ileal bypass for type II diabetes: a systematic review [0.03%]
单吻合肠道旁路手术和单吻合胃肠旁路手术治疗2型糖尿病的疗效：系统性综述
Hye Rim Suh,Jasmine Mui,Ernest Cheng et al.
Hye Rim Suh et al.
Introduction: Bariatric surgery has demonstrated long-term effectiveness in inducing weight loss and improving metabolic parameters for obesity. Single anastomosis duodeno-ileal (SADI) bypass and single anastomosis sleeve...
Bone health and prevalent fractures in women with polycystic ovary syndrome: a meta-analysis and endocrine-context pathophysiology review [0.03%]
多囊卵巢综合征女性的骨健康和骨折现状：meta分析与内分泌病理生理学综述
Jerilynn C Prior,Sonia Shirin,Azita Goshtasebi
Jerilynn C Prior
Introduction: Bone health in those with Polycystic Ovary Syndrome (PCOS) is complex, but the general consensus is that cortical areal bone mineral density (aBMD) sites will be higher in PCOS than in age- and BMI-similar c...
Roberta Balestrino,Marco Losa,Luigi Albano et al.
Roberta Balestrino et al.
Introduction: Known for its effect on labor and lactation and on emotional and social functions, oxytocin has recently emerged as a key modulator of feeding behavior and indeed suggested as a potential treatment for obesi...
Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study [0.03%]
印度常用二肽基肽酶-4抑制剂的成本效益分析系统研究
Harmanjit Singh,Ekta Arora,Seerat Narula et al.
Harmanjit Singh et al.
Objective: To identify a preferred and cost-effective drug among Dipeptidyl peptidase-4 inhibitors (DPP4Is) for Indian patients with T2DM. Methods: ...
Pharmacotherapy for obesity: recent evolution and implications for cardiovascular risk reduction [0.03%]
肥胖的药物治疗：近年来的发展及其对心血管风险降低的意义
Kevin C Maki,Carol F Kirkpatrick,David B Allison et al.
Kevin C Maki et al.
Introduction: Obesity is highly prevalent in the U.S. and is associated with an increased risk of major adverse cardiovascular events (MACE). Modalities for the management of obesity include lifestyle intervention, pharma...
The current role of SGLT2 inhibitors in type 2 diabetes and beyond: a narrative review [0.03%]
钠-葡萄糖协同转运蛋白2抑制剂在2型糖尿病及其他疾病中的作用：叙述性综述
André J Scheen
André J Scheen
Introduction: Sodium-glucose cotransporter 2 inhibitors (SGLT2is, gliflozins), the most recent oral antihyperglycaemic agents, provide a cardiorenal protection, an effect independent of their glucose-lowering potency. ...
Laura Statham,Melina Pelling,Petra Hanson et al.
Laura Statham et al.
Introduction: To date, the 21st Century has witnessed key developments in the management of diabesity (a conflation of obesity and Type 2 Diabetes Mellitus [T2D]), including Glucagon Like Peptide 1 (GLP1) receptor agonist...
Praneet K Gill,Robert A Hegele
Praneet K Gill
Introduction: Hypocholesterolemia results from genetic - both monogenic and polygenic - and non-genetic causes and can sometimes be a source of clinical concern. We review etiologies and sequelae of hypocholesterolemia an...
Gulali Aktas,Burcin Meryem Atak Tel,Ramiz Tel et al.
Gulali Aktas et al.
Introduction: While type 2 diabetes mellitus (T2DM) increases the risk of cardiac complications, diabetes treatment choices may increase or decrease the rates of cardiac events. In the present review, we comprehensively d...